Items related to Mergers & Acquisitions in the Pharmaceutical Industry
- ISBN 10 3330070439
- ISBN 13 9783330070431
- BindingPaperback
Buy New
Learn more about this copy
US$ 19.86
Shipping:
US$ 24.77
From Germany to U.S.A.
Top Search Results from the AbeBooks Marketplace
Seller Image
Mergers & Acquisitions in the Pharmaceutical Industry
Published by
LAP Lambert Academic Publishing Mai 2017
(2017)
ISBN 10: 3330070439
ISBN 13: 9783330070431
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Abnormal returns in stock markets are subject to many studies. In particular, the ability to test on specific industries has received much attention. The number of M&As have increased in the last decade, which also includes M&A deals in the pharmaceutical (pharma) industry, where companies acquire to reach distinctive capabilities to survive in the dynamic and complex business environment. Companies also utilize M&A to increase their ability to create shareholder wealth, though this has shown partially not to be correct. Previous studies conducted, have found rather different results on M&A transactions. This thesis examines the impact on shareholder wealth in pharmaceutical M&As, more precise the study tests the abnormal stock return around the announcement day. The study is conducted with a data sample consisting of 250 deals in the pharma industry between 2000 and 2014. 80 pp. Englisch. Seller Inventory # 9783330070431
Buy New
US$ 19.86
Convert currency
Seller Image
Mergers & Acquisitions in the Pharmaceutical Industry : An empirical study of acquirers' ability to create shareholder wealth
Published by
LAP Lambert Academic Publishing
ISBN 10: 3330070439
ISBN 13: 9783330070431
New
Taschenbuch
Quantity: 1
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Abnormal returns in stock markets are subject to many studies. In particular, the ability to test on specific industries has received much attention. The number of M&As have increased in the last decade, which also includes M&A deals in the pharmaceutical (pharma) industry, where companies acquire to reach distinctive capabilities to survive in the dynamic and complex business environment. Companies also utilize M&A to increase their ability to create shareholder wealth, though this has shown partially not to be correct. Previous studies conducted, have found rather different results on M&A transactions. This thesis examines the impact on shareholder wealth in pharmaceutical M&As, more precise the study tests the abnormal stock return around the announcement day. The study is conducted with a data sample consisting of 250 deals in the pharma industry between 2000 and 2014. Seller Inventory # 9783330070431
Buy New
US$ 19.86
Convert currency
Seller Image
Mergers & Acquisitions in the Pharmaceutical Industry
Published by
LAP LAMBERT Academic Publishing
(2017)
ISBN 10: 3330070439
ISBN 13: 9783330070431
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Nguyen Jimmy Thien PhuJimmy Thien Phu Nguyen and Thomas Grauer Nielsen are currently two MSc. Finance & International Business students at Aarhus University BSS with a goal to erode the gap between theory and practice.Abnormal re. Seller Inventory # 151236191
Buy New
US$ 19.77
Convert currency